Package 69238-2693-1

Brand: cabergoline

Generic: cabergoline
NDC Package

Package Facts

Identity

Package NDC 69238-2693-1
Digits Only 6923826931
Product NDC 69238-2693
Description

8 TABLET in 1 BOTTLE (69238-2693-1)

Marketing

Marketing Status
Marketed Since 2024-10-03
Brand cabergoline
Generic cabergoline
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3e2ff3e8-fa09-469e-b545-68ab6b168de7", "openfda": {"nui": ["M0007652", "N0000175827"], "upc": ["0369238269314"], "unii": ["LL60K9J05T"], "rxcui": ["199703"], "spl_set_id": ["a246b015-e19c-4b4f-9089-aea1108687ba"], "pharm_class_cs": ["Ergolines [CS]"], "pharm_class_epc": ["Ergot Derivative [EPC]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "8 TABLET in 1 BOTTLE (69238-2693-1)", "package_ndc": "69238-2693-1", "marketing_start_date": "20241003"}], "brand_name": "Cabergoline", "product_id": "69238-2693_3e2ff3e8-fa09-469e-b545-68ab6b168de7", "dosage_form": "TABLET", "pharm_class": ["Ergolines [CS]", "Ergot Derivative [EPC]"], "product_ndc": "69238-2693", "generic_name": "Cabergoline", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cabergoline", "active_ingredients": [{"name": "CABERGOLINE", "strength": ".5 mg/1"}], "application_number": "ANDA218618", "marketing_category": "ANDA", "marketing_start_date": "20241003", "listing_expiration_date": "20261231"}